Epigenetic Carcinogenesis and Malignancy: The Significance of Migratory Potential





Logistic growth model, cellular altruism, migratory limitation, malignant phenotype, penetration of tissue barriers, epigenetic error, faulty epigenetic copying at mitosis, metastasis


The essential feature of the malignant phenotype is the ability of the affected cells to transgress the normal territorial limits that delineate tissue boundaries. This brief review outlines the process underlying the acquisition of this property based on evidence consistent with the notion that the mechanism of carcinogenesis involves defective epigenetic transmission. The resulting failure of vertical transmission of the differentiated pattern of gene expression in proliferative stem cells which leads to faulty copying of the epigenetic information at each cell division generates widespread genetic abnormalities; a process which is essentially equivalent to a greatly elevated mutation rate. The outcome from the point of view of the affected cell and its progeny would be expected to interfere negatively with the proliferation rate. To some extent this proliferative disadvantage is offset by the altruistic factor necessary for permitting coexistence of different cell types in multicellular organisms but the crucial property which renders certain cells malignant is their ability to transgress tissue boundaries. Affected cells possessing this malignant phenotype are able to penetrate this barrier and enter microenvironmental zones where they are able to proliferate without competition. The competitive growth process is outlined using a simple microenvironmental model.


Riley PA. Cancer: Evidence Consistent with Epigenetic Carcinogenesis. J. Cancer Research Updates 2022: 11: 39-42. https://doi.org/10.30683/1929-2279.2022.11.06 DOI: https://doi.org/10.30683/1929-2279.2022.11.06

Riley PA. Epimutation and Cancer: Carcinogenesis Viewed as Error-prone Inheritance of Epigenetic Information. J Oncology 2018; 1-4. https://doi.org/10.1155/2018/2645095 DOI: https://doi.org/10.1155/2018/2645095

Riley PA. Epigenetic Error and Large-scale Genomic Instability in Cancer. Biomed J Sci & Tech Res 2018; 4: 1-4. https://doi.org/10.26717/BJSTR.2018.04.0001057 DOI: https://doi.org/10.26717/BJSTR.2018.04.0001057

Landolt RM, Vaughan Ll, Winterhalter KH, Zimmermann DR. Versican is selectively expressed in embryonic tissue that act as barriers to neural crest cell migration and axon outgrowth. Development 1995; 121: 2303-2312. https://doi.org/10.1242/dev.121.8.2303 DOI: https://doi.org/10.1242/dev.121.8.2303

Hall BK. The Neural Crest and Neural Crest Cells in Vertebrate Development and Evolution. Springer: New York 2009. https://doi.org/10.1007/978-0-387-09846-3 DOI: https://doi.org/10.1007/978-0-387-09846-3

Woodward C, Davidson EA. Structure-function relationship of protein polysaccharide complexes: specific ion-binding properties. Biochemistry 1968; 60: 201-205. https://doi.org/10.1073/pnas.60.1.201 DOI: https://doi.org/10.1073/pnas.60.1.201

Elices MJ, Urry LA, Hemler ME. Receptor functions for the Integrin VLA-3: Fibronectin, collagen, and Laminin Binding are differentially influenced by ARG-GLY-ASP peptide and by divalent cations. J Cell Biol 1991; 112: 169-181. https://doi.org/10.1083/jcb.112.1.169 DOI: https://doi.org/10.1083/jcb.112.1.169

Ruoslahti E. Proteoglycans in cell regulation. J Biol Chem 1989; 264: 13369-13372. https://doi.org/10.1016/S0021-9258(18)80001-1 DOI: https://doi.org/10.1016/S0021-9258(18)80001-1

Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991; 71: 481-538. https://doi.org/10.1152/physrev.1991.71.2.481 DOI: https://doi.org/10.1152/physrev.1991.71.2.481

Toole BP. Proteoglycans and hyaluranan in morphogenesis and differentiation. In: Cell Biology of Extracellular Matrix (ed. E.D. Hay). Plenum Press: New York 1991; pp. 305-341. https://doi.org/10.1007/978-1-4615-3770-0_10 DOI: https://doi.org/10.1007/978-1-4615-3770-0_10

Margolis RK, Margolis RU. Nervous tissue polyglycans. Experientia 1993; 49: 429-446. https://doi.org/10.1007/BF01923587 DOI: https://doi.org/10.1007/BF01923587

Oakley RA, Lasky CJ, Erickson CA, Tosney KW. Glycoconjugates mark a transient barrier to neural crest migration in the chicken embryo. Development 1994; 120: 103-114. https://doi.org/10.1242/dev.120.1.103 DOI: https://doi.org/10.1242/dev.120.1.103

Grant GT, Morris ER, Rees DA, Smith PJC, Thom D. Biological interactions between polysaccharides and divalent cations: the egg-box model. FEBS Lett 1973; 32: 195-198. https://doi.org/10.1016/0014-5793(73)80770-7 DOI: https://doi.org/10.1016/0014-5793(73)80770-7

Braccini I, Grasso RP, Perez S. Conformational and configurational of acidic polysaccharides and their interactions with calcium ions: a molecular modelling investigation. Carbohydrate Res 1999; 317: 119-130. https://doi.org/10.1016/S0008-6215(99)00062-2 DOI: https://doi.org/10.1016/S0008-6215(99)00062-2

Couchman JR, Pataki CA. An introduction to proteoglycans and their localisation. J Histochem Cytochem 2012; 60: 885-897. https://doi.org/10.1369/0022155412464638 DOI: https://doi.org/10.1369/0022155412464638

Stanton H, Melrose J, Little CB, Fosang AJ. Proteoglycan degradation by the ADAMTS family of proteinases. Biochim Biophys Acta 2011; 1812: 1616-1629. https://doi.org/10.1016/j.bbadis.2011.08.009 DOI: https://doi.org/10.1016/j.bbadis.2011.08.009

Cal S, Lopez-Otin C. ADAMTS proteases and cancer. Matrix Biol 2015; 44-46: 77-85. https://doi.org/10.1016/j.matbio.2015.01.013 DOI: https://doi.org/10.1016/j.matbio.2015.01.013

Riley PA. Epigenetic carcinogenesis and genetic instability: competitive aspects of the malignant phenotype. J Mol Oncol Res 2018; 2: 1-3. https://doi.org/10.35841/molecular-oncology.2.2.42-44 DOI: https://doi.org/10.35841/molecular-oncology.2.2.42-44

Riley PA. Cellular Proliferative Domains: Barriers to Migration. Cancer Nature.

Wang CY, Lai MD, Phan NN, Sun Z, Lin YC. Meta-analysis of public microarray datasets reveals voltage-gated calcium gene signatures in clinical cancer patients. PLoS One 2015; 10: e0125766. https://doi.org/10.1371/journal.pone.0125766 DOI: https://doi.org/10.1371/journal.pone.0125766




How to Cite

Riley, P. A. (2023). Epigenetic Carcinogenesis and Malignancy: The Significance of Migratory Potential. Journal of Cancer Research Updates, 12, 40–43. https://doi.org/10.30683/1929-2279.2023.12.7